Omada Health, Inc. (OMDA)

NASDAQ: OMDA · Real-Time Price · USD
17.54
+1.85 (11.79%)
At close: Jun 25, 2025, 4:00 PM
17.63
+0.09 (0.51%)
Pre-market: Jun 26, 2025, 8:52 AM EDT

Omada Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
189.67169.8122.7889.19
Revenue Growth (YoY)
-38.29%37.67%-
Cost of Revenue
72.2466.9252.8146.39
Gross Profit
117.43102.8869.9742.79
Selling, General & Admin
115.65110.61102.2388.97
Research & Development
35.8335.9233.7426.17
Operating Expenses
151.49146.53135.97115.14
Operating Income
-34.06-43.65-66-72.35
Interest Expense
-4.45-4.51-4.71-4.2
Interest & Investment Income
0.820.815.782.2
Other Non Operating Income (Expenses)
0.070.22-1.051.83
EBT Excluding Unusual Items
-37.62-47.14-65.98-72.52
Other Unusual Items
---1.54-
Pretax Income
-37.62-47.14-67.51-72.52
Net Income
-37.62-47.14-67.51-72.52
Net Income to Common
-37.62-47.14-67.51-72.52
Shares Outstanding (Basic)
8877
Shares Outstanding (Diluted)
8877
Shares Change (YoY)
-8.89%4.59%-
EPS (Basic)
-4.76-6.10-9.52-10.70
EPS (Diluted)
-4.76-6.10-9.52-10.70
Free Cash Flow
-30.38-34.78-50.15-69.7
Free Cash Flow Per Share
-3.84-4.50-7.07-10.28
Gross Margin
61.91%60.59%56.99%47.98%
Operating Margin
-17.96%-25.71%-53.75%-81.12%
Profit Margin
-19.83%-27.76%-54.98%-81.31%
Free Cash Flow Margin
-16.02%-20.48%-40.85%-78.15%
EBITDA
-29.05-38.85-61.55-68.02
EBITDA Margin
-15.31%-22.88%-50.13%-76.27%
D&A For EBITDA
5.014.84.454.33
EBIT
-34.06-43.65-66-72.35
EBIT Margin
-17.96%-25.71%-53.75%-81.12%
Revenue as Reported
189.67169.8122.7889.19
Advertising Expenses
-0.50.80.7
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q